AL
Andrew Lo (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $6.3M of BBIO (95,599 sh across 4 lots, as filed), executed Nov 17 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 18 2025
Filed Nov 19 2025
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $10.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$6.3M95,599 sh across 4 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $3.9M
100,000 sh × $38.50
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET